Vital Farms Reports Third Quarter 2020 Financial Results
Vital Farms reported a 57% increase in net revenue to $53.4 million for Q3 2020, driven by higher demand for eggs and butter due to COVID-19. Gross profit rose to $18.4 million with a gross margin increase of over 300 basis points. Net income reached $1.7 million, doubling from the previous year, while adjusted EBITDA was $3.7 million. The company expects full-year 2020 revenue between $210 million to $214 million, representing a growth of over 49%. Despite strong performance, there is uncertainty regarding sustained demand post-pandemic.
- Net revenue up 57% to $53.4 million.
- Gross profit increased to $18.4 million with gross margin up 300 basis points.
- Net income doubled to $1.7 million compared to prior year.
- Adjusted EBITDA rose to $3.7 million from $1.9 million.
- Uncertainty about sustained demand post-COVID-19 pandemic.
- Sales incentives partially offset revenue growth.
Net Revenue Increased to
Gross Profit of
Net Income of $1.7 Million, Compared to $0.8 Million Last Year
Adjusted EBITDA of $3.7 Million, Compared to
AUSTIN, Texas, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced pasture-raised foods nationwide, today reported financial results for its third quarter ended September 27, 2020.
“We are pleased to report strong third quarter results including continued growth in the number of households choosing our products and consumers making repeat purchases, both of which were driven in part by sustained at-home consumption trends as a result of COVID-19,” said Russell Diez-Canseco, President and Chief Executive Officer, Vital Farms. “Looking ahead, we remain focused on building a trusted ethical food brand and executing our growth strategy to further increase our household penetration and presence in retail as well as ongoing product innovation. Our strategy is underpinned by an unwavering commitment to prioritizing our stakeholders who have worked tirelessly throughout the pandemic including our small family farm partners, dedicated crew members, and the communities in which we operate. Vital Farms serves a robust market, and we believe our premium brand is strategic and valuable for retailers as more consumers are seeking ethically produced foods.”
For the Three Months Ended September 27, 2020
Net revenue increased
Gross profit was
Income from operations in the third quarter of 2020 was
Net income was
Net income per diluted share increased
Adjusted EBITDA, was
Jason Dale, Chief Financial Officer and Chief Operating Officer commented, “We are pleased with our strong results this quarter. As we look ahead at the robust market for ethically produced food, including food produced from humanely-raised animals, we believe we have a unique opportunity at Vital Farms to achieve strong growth today and for many years to come.”
Balance Sheet and Cash Flow Highlights
The Company’s cash and cash equivalents were
Capital expenditures totaled
Update on COVID-19 and Fiscal 2020 Outlook
The Company’s guidance continues to assume that there are no additional, significant disruptions to the supply chain, its customers or consumers, including any issues from adverse macroeconomic factors. In addition, the Company’s guidance reflects the expectation that in the back half of the year, the Company will continue to see elevated demand due to the stay-at-home trends associated with COVID-19, and will continue to allocate demand against the available shell egg supply. Given the uncertainty regarding the ultimate duration, magnitude and effects of the COVID-19 pandemic, we do not have certainty that these trends will continue.
- For the full year 2020, management expects net revenue between
$210 t o$214 million , an increase of greater than49% compared to 2019. - Adjusted EBITDA is anticipated to be in the range of
$16 t o$18 million .
The Company cannot provide a reconciliation between its forecasted Adjusted EBITDA and net revenue metrics without unreasonable effort due to the unavailability of reliable estimates for certain items. These items are not within the Company’s control and may vary greatly between periods and could significantly impact future financial results.
Conference Call and Webcast Details
The Company will host a conference call and webcast at 8:30 a.m. ET today to discuss the results. The live conference call webcast can be accessed on the Vital Farms Investor Relations website at https://investors.vitalfarms.com under “Events.” The webcast will be also be archived.
About Vital Farms
Vital Farms, a Certified B Corporation, offers a range of ethically produced pasture-raised foods nationwide. Started on a single farm in Austin, Texas, in 2007, Vital Farms is the leading U.S. brand of pasture-raised eggs and butter by retail dollar sales. Vital Farms' ethics are exemplified by its focus on the humane treatment of farm animals and sustainable farming practices. In addition, as a Delaware Public Benefit Corporation, Vital Farms also prioritizes the long-term benefits of each of its stakeholders, including farmers and suppliers, customers and consumers, communities and the environment, and crew members and stockholders. Vital Farms' pasture-raised products, including shell eggs, butter, hard-boiled eggs, ghee, Egg Bites and liquid whole eggs, are sold in approximately 16,000 stores nationwide.
Forward-Looking Statements
This press release and the earnings call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Vital Farms’ future financial performance, including our outlook for fiscal year 2020. These forward-looking statements are based on Vital Farms’ current assumptions, expectations and beliefs and are subject to substantial risks, uncertainties, assumptions and changes in circumstances that may cause Vital Farms’ actual results, performance or achievements to differ materially from those expressed or implied in any forward-looking statement.
The risks and uncertainties referred to above include, but are not limited to: (1) the effects of the current COVID-19 pandemic, or of other global outbreaks of pandemics or contagious diseases or fear of such outbreaks, including on our supply chain, the demand for our products, and on overall economic conditions and consumer confidence and spending levels; (2) our expectations regarding our revenue, expenses and other operating results; (3) our ability to acquire new customers and successfully retain existing customers; (4) our ability to attract and retain our suppliers, distributors and co-manufacturers; (5) our ability to sustain or increase our profitability; (6) our ability to procure sufficient high quality eggs, butter and other raw materials; (7) real or perceived quality with our products or other issues that adversely affect our brand and reputation; (8) changes in the tastes and preferences of our consumers; (9) the financial condition of, and our relationships with, our suppliers, co-manufacturers, distributors, retailers and foodservice customers, as well as the health of the foodservice industry generally; (10) real or perceived quality or health issues with our products or other issues that adversely affect our brand and reputation; (11) the ability of our suppliers and co-manufacturers to comply with food safety, environmental or other laws or regulations; (12) future investments in our business, our anticipated capital expenditures and our estimates regarding our capital requirements; (13) the costs and success of our marketing efforts, and our ability to promote our brand; (14) our reliance on key personnel and our ability to identify, recruit and retain skilled personnel; (15) our ability to effectively manage our growth; (16) our focus on a specific public benefit purpose and producing a positive effect for society may negatively influence our financial performance; (17) our ability to compete effectively with existing competitors and new market entrants; (18) the impact of adverse economic conditions; (19) the sufficiency of our cash to meet our liquidity needs and service our indebtedness; (20) seasonality; and (21) the growth rates of the markets in which we compete.
These risks and uncertainties are more fully described in our filings with the Securities and Exchange Commission, including in the section entitled “Risk Factors” in our quarterly report on Form 10-Q for the fiscal quarter ended September 27, 2020 and other filings and reports that we may file from time to time with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, we cannot guarantee future results, levels of activity, performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. Forward-looking statements represent our beliefs and assumptions only as of the date of this press release. We disclaim any obligation to update forward-looking statements except as required by law.
Contacts:
Media:
Nisha Devarajan
Nisha.Devarajan@vitalfarms.com
Investors:
Ashley DeSimone
Ashley.DeSimone@icrinc.com
| VITAL FARMS, INC. | ||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
| (Amounts in thousands, except share amounts) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| 13-Weeks Ended | 39-Weeks Ended | |||||||||||||||
| September 27, 2020 | September 29, 2019 | September 27, 2020 | September 29, 2019 | |||||||||||||
| Net revenue | $ | 53,367 | $ | 34,082 | $ | 160,287 | $ | 99,312 | ||||||||
| Cost of goods sold | 35,017 | 23,484 | 103,384 | 66,208 | ||||||||||||
| Gross profit | 18,350 | 10,598 | 56,903 | 33,104 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general and administrative | 12,185 | 7,069 | 31,832 | 16,991 | ||||||||||||
| Shipping and distribution | 3,752 | 2,345 | 10,693 | 6,757 | ||||||||||||
| Total operating expenses | 15,937 | 9,414 | 42,525 | 23,748 | ||||||||||||
| Income from operations | 2,413 | 1,184 | 14,378 | 9,356 | ||||||||||||
| Other (expense) income, net: | ||||||||||||||||
| Interest expense | (110 | ) | (85 | ) | (365 | ) | (250 | ) | ||||||||
| Other (expense) income, net | (21 | ) | 47 | (182 | ) | 1,369 | ||||||||||
| Total other (expense) income, net | (131 | ) | (38 | ) | (547 | ) | 1,119 | |||||||||
| Net income before income taxes | 2,282 | 1,146 | 13,831 | 10,475 | ||||||||||||
| Provision for income taxes | 620 | 323 | 4,300 | 2,839 | ||||||||||||
| Net income | 1,662 | 823 | 9,531 | 7,636 | ||||||||||||
| Less: Net (loss) income attributable to noncontrolling interests | (15 | ) | (6 | ) | (54 | ) | 950 | |||||||||
| Net income attributable to Vital Farms, Inc. common stockholders | $ | 1,677 | $ | 829 | $ | 9,585 | $ | 6,686 | ||||||||
| Net income per share attributable to Vital Farms, Inc. stockholders: | ||||||||||||||||
| Basic: | $ | 0.05 | $ | 0.03 | $ | 0.33 | $ | 0.26 | ||||||||
| Diluted: | $ | 0.04 | $ | 0.02 | $ | 0.29 | $ | 0.18 | ||||||||
| Weighted average common shares outstanding: | ||||||||||||||||
| Basic: | 34,044,994 | 25,929,923 | 28,664,914 | 26,197,567 | ||||||||||||
| Diluted: | 39,111,018 | 37,472,406 | 33,275,902 | 36,959,507 | ||||||||||||
| VITAL FARMS, INC. | ||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
| (Amounts in thousands, except share amounts) | ||||||||
| September 27, 2020 | December 29, 2019 | |||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 112,619 | $ | 1,274 | ||||
| Accounts receivable, net | 17,551 | 16,108 | ||||||
| Inventories | 11,728 | 12,947 | ||||||
| Income taxes receivable | 322 | 1,615 | ||||||
| Prepaid expenses and other current assets | 3,681 | 2,706 | ||||||
| Total current assets | 145,901 | 34,650 | ||||||
| Property, plant and equipment, net | 27,692 | 22,458 | ||||||
| Notes receivable from related party | — | 831 | ||||||
| Goodwill | 3,858 | 3,858 | ||||||
| Deposits and other assets | 142 | 151 | ||||||
| Total assets | $ | 177,593 | $ | 61,948 | ||||
| Liabilities, Redeemable Noncontrolling Interest, Redeemable Convertible Preferred Stock and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 16,052 | $ | 13,510 | ||||
| Accrued liabilities | 7,933 | 8,608 | ||||||
| Current portion of long-term debt | 1,104 | 2,160 | ||||||
| Lease obligation, current | 465 | 449 | ||||||
| Contingent consideration, current | 138 | 270 | ||||||
| Income taxes payable | 364 | — | ||||||
| Total current liabilities | 26,056 | 24,997 | ||||||
| Long-term debt, net of current portion | 6,480 | 2,896 | ||||||
| Lease obligation, net of current portion | 447 | 797 | ||||||
| Contingent consideration, non-current | 32 | 382 | ||||||
| Deferred tax liabilities, net | 2,137 | 755 | ||||||
| Other liability, non-current | 422 | 272 | ||||||
| Total liabilities | 35,574 | 30,099 | ||||||
| Commitments and contingencies (Note 15) | ||||||||
| Redeemable noncontrolling interest | 175 | 175 | ||||||
| Redeemable convertible preferred stock (Series B, Series C and Series D), | — | 23,036 | ||||||
| Stockholders’ equity: | ||||||||
| Common stock, | 5 | 3 | ||||||
| Treasury stock, at cost, 5,494,918 common shares as of September 27, 2020 (unaudited) and December 29, 2019 | (16,276 | ) | (16,276 | ) | ||||
| Additional paid-in capital | 143,265 | 19,593 | ||||||
| Retained earnings | 14,825 | 5,239 | ||||||
| Total stockholders’ equity attributable to Vital Farms, Inc. stockholders | 141,819 | 8,559 | ||||||
| Noncontrolling interests | 25 | 79 | ||||||
| Total stockholders’ equity | $ | 141,844 | $ | 8,638 | ||||
| Total liabilities, redeemable noncontrolling interest, redeemable convertible preferred stock and stockholders’ equity | $ | 177,593 | $ | 61,948 | ||||
| VITAL FARMS, INC. | ||||||||
| CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS | ||||||||
| (Amounts in thousands) | ||||||||
| (Unaudited) | ||||||||
| 39-Weeks Ended | ||||||||
| September 27, 2020 | September 29, 2019 | |||||||
| Cash flows provided by operating activities: | ||||||||
| Net income | $ | 9,531 | $ | 7,636 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 1,568 | 1,119 | ||||||
| Non-cash interest expense | 5 | 16 | ||||||
| Bad debt recovery | (63 | ) | — | |||||
| Inventory provisions | 155 | (137 | ) | |||||
| Change in fair value of contingent consideration | (342 | ) | 53 | |||||
| Stock-based compensation expense | 1,481 | 576 | ||||||
| Loss on write-off of construction in progress | 259 | — | ||||||
| Deferred taxes | 1,382 | — | ||||||
| Non-cash interest income | (14 | ) | (106 | ) | ||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (1,380 | ) | (3,320 | ) | ||||
| Inventories | 1,063 | (9,481 | ) | |||||
| Income taxes receivable | 1,293 | — | ||||||
| Income taxes payable | 364 | 660 | ||||||
| Prepaid expenses and other current assets | (1,970 | ) | 42 | |||||
| Deposits and other assets | 11 | 77 | ||||||
| Accounts payable | 2,207 | 1,928 | ||||||
| Accrued liabilities and other liabilities | (507 | ) | 1,039 | |||||
| Net cash provided by operating activities | $ | 15,043 | $ | 102 | ||||
| Cash flows used in investing activities: | ||||||||
| Purchases of property, plant and equipment | (6,728 | ) | (3,089 | ) | ||||
| Notes receivable provided to related parties | — | (4,000 | ) | |||||
| Repayment of notes receivable provided to related parties | 846 | — | ||||||
| Net cash used in investing activities | $ | (5,882 | ) | $ | (7,089 | ) | ||
| Cash flows provided by (used in) financing activities: | ||||||||
| Proceeds from issuance of common stock pursuant to the initial public offering, net of issuance costs | 99,671 | — | ||||||
| Proceeds from borrowings under term loan | 5,000 | — | ||||||
| Proceeds from borrowings under equipment loan | 1,461 | — | ||||||
| Proceeds from Paycheck Protection Program loan | 2,593 | — | ||||||
| Proceeds from issuance of common stock, net of issuance costs | — | 14,097 | ||||||
| Repayment of revolving line of credit | (1,325 | ) | — | |||||
| Repayment of equipment loan | (2,015 | ) | — | |||||
| Repayment of term loan | (618 | ) | (503 | ) | ||||
| Repayment of Paycheck Protection Program loan | (2,593 | ) | — | |||||
| Repurchase of common stock | — | (14,289 | ) | |||||
| Payment of contingent consideration | (140 | ) | (322 | ) | ||||
| Principal payments under finance lease obligation | (335 | ) | (319 | ) | ||||
| Proceeds from exercise of stock options | 203 | 218 | ||||||
| Proceeds from exercise of warrant | 282 | — | ||||||
| Net cash provided by (used in) financing activities | $ | 102,184 | $ | (1,118 | ) | |||
| Net increase in cash and cash equivalents | $ | 111,345 | $ | (8,105 | ) | |||
| Cash and cash equivalents at beginning of the period | 1,274 | 11,815 | ||||||
| Cash and cash equivalents at end of the period | $ | 112,619 | $ | 3,710 | ||||
| Supplemental disclosure of cash flow information: | ||||||||
| Cash paid for interest | $ | 358 | $ | 265 | ||||
| Cash paid for income taxes | $ | 1,150 | $ | 2,056 | ||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||||||
| Purchases of property, plant and equipment included in accounts payable and accrued liabilities | $ | 331 | $ | 122 | ||||
Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that Adjusted EBITDA, a non-GAAP financial measure, provides investors with additional useful information in evaluating our performance.
We calculate Adjusted EBITDA as net income, adjusted to exclude: (1) depreciation and amortization; (2) provision for income taxes; (3) stock-based compensation expense; (4) interest expense; (5) interest income; (6) change in fair value of contingent consideration; and (7) net litigation settlement gain.
Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with GAAP. We believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a measure used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes.
Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA include that (1) it does not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures, (3) it does not consider the impact of stock-based compensation expense, (4) it does not reflect other non-operating expenses, including interest expense, (5) it does not consider the impact of any contingent consideration liability valuation adjustments and (6) it does not reflect tax payments that may represent a reduction in cash available to us. In addition, our use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as a comparative measure. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA alongside other financial measures, including our net income and other results stated in accordance with GAAP.
The following table presents a reconciliation of Adjusted EBITDA to net income, the most directly comparable financial measure stated in accordance with GAAP, for the quarters presented:
| 13-Weeks Ended | 39-Weeks Ended | |||||||||||
| September 27, 2020 | September 29, 2019 | September 27, 2020 | September 29, 2019 | |||||||||
| (in thousands) | ||||||||||||
| Net income | $ | 1,662 | $ | 823 | $ | 9,531 | $ | 7,636 | ||||
| Depreciation and amortization | 614 | 370 | 1,568 | 1,119 | ||||||||
| Provision for income tax | 620 | 323 | 4,300 | 2,839 | ||||||||
| Stock-based compensation expense | 737 | 290 | 1,481 | 576 | ||||||||
| Interest expense | 110 | 85 | 365 | 250 | ||||||||
| Change in fair value of contingent consideration (1) | 8 | 15 | (342) | 53 | ||||||||
| Interest income | (10) | (45) | (24) | (140) | ||||||||
| Net litigation settlement gain (2) | — | — | (20) | (1,200) | ||||||||
| Adjusted EBITDA | $ | 3,741 | $ | 1,861 | $ | 16,859 | $ | 11,133 | ||||
| (1) | Amount reflects the change in fair value of a contingent consideration liability in connection with our 2014 acquisition of certain assets of Heartland Eggs |
| (2) | For the 39-week period ended September 29, 2019, amount reflects a gain in connection with the settlement of the Ovabrite lawsuit. |
FAQ
What are the financial results for VITL in Q3 2020?
How did Vital Farms' net income change in Q3 2020?
What is the revenue outlook for VITL for the full year 2020?
What factors drove Vital Farms' revenue growth in Q3 2020?
